Oral minoxidil treatment for hair loss: A review of efficacy and safety.
💡 한 문장 핵심
탈모에 대한 경구 minoxidil 치료: 유효성과 안전성에 관한 고찰.
5/5 보강
TL;DR
Oral minoxidil was found to be an effective and well-tolerated treatment alternative for healthy patients having difficulty with topical formulations and will be needed to clarify the best treatment protocol.
PICO 자동 추출 (휴리스틱, conf 2/4)
유사 논문P · Population 대상 환자/모집단
634 patients were found discussing the use of oral minoxidil as the primary treatment modality for hair loss.
I · Intervention 중재 / 시술
추출되지 않음
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
[LIMITATIONS] Larger randomized studies comparing the efficacy/safety of different doses with standardized objective measurements will be needed to clarify the best treatment protocol. [CONCLUSION] Oral minoxidil was found to be an effective and well-tolerated treatment alternative for healthy patients having difficulty with topical formulations.
📑 코퍼스 인용 관계
· 인용됨 74
📑 인용한 논문 (6) ▾
- Oral Minoxidil for Alopecia Treatment: Risks, Benefits, and Recommendations. American journal of clinical dermatology · 2026
- Dermal T cell immunity and key regulatory signaling pathways: Implications in immune-media… Genes & diseases · 2025
- Gender Differences in Adverse Effects and Dosing Practices of Low-Dose Oral Minoxidil for … Skin appendage disorders · 2025
- Minoxidil Overdose: A Case Report and Review of the Literature. Cureus · 2025
- The value of speckle tracking echocardiography in diagnosing minoxidil-induced cardiotoxic… Journal of ultrasound · 2025
- Effectiveness of Combined Oral Minoxidil and Finasteride in Male Androgenetic Alopecia: A … Cureus · 2025
연도별 인용 (2014–2026) · 합계 250
OpenAlex 토픽 ·
Hair Growth and Disorders
Dermatologic Treatments and Research
Oral health in cancer treatment
🇰🇷 한글 요약 🌐 Abstract
【연구 목적】
국소 미녹시딜(topical minoxidil)은 효과적인 탈모 치료제이나 1일 2회 도포의 번거로움, 모발 결의 변화, 두피 자극 등으로 순응도가 낮은 한계가 있다. 본 연구는 저용량 경구 미녹시딜(oral minoxidil)이 국소 제형의 대안으로서 유효성과 안전성을 갖는지 문헌 고찰을 통해 평가하였다.
【방법】
2020년 4월까지 PubMed에서 경구 미녹시딜을 탈모의 일차 치료로 사용한 연구를 검색하여 분석하였다. 총 17편의 연구, 634명의 환자 데이터를 대상으로 하였다.
【주요 결과】
가장 많이 연구된 적응증은 안드로겐성 탈모(androgenetic alopecia)였으며, 그 외 휴지기 탈모(telogen effluvium), 편평태선성 모낭염(lichen planopilaris), 이완성 성장기 모발 증후군(loose anagen hair syndrome), 염주모(monilethrix), 원형 탈모증(alopecia areata), 항암제 유발 영구 탈모(permanent chemotherapy-induced alopecia)에서도 사용되었다. 전반적으로 경구 미녹시딜은 효과적이며 내약성이 우수한 것으로 보고되었다.
【임상적 시사점 (성형외과 의사 관점)】
국소 미녹시딜 도포에 어려움을 겪거나 두피 자극·모발 결 변화로 중단한 환자에게 저용량 경구 미녹시딜을 대안으로 고려할 수 있어, 모발이식 전후 보조요법이나 비수술적 탈모 치료 옵션의 폭을 넓힐 수 있다. 다만 용량별 효능·안전성을 비교한 대규모 무작위 연구가 부족하므로, 처방 시 심혈관계 부작용(다모증, 부종, 빈맥 등) 모니터링과 환자 선별이 중요하다. 안드로겐성 탈모 외 다양한 탈모 유형에서도 활용 가능성이 있어 진료 범위 확장에 참고할 만하다.
[BACKGROUND] Although topical minoxidil is an effective treatment option for hair loss, many patients are poorly compliant because of the necessity to apply the medication twice a day, undesirable hair texture, and scalp irritation.
[OBJECTIVE] In recent years, oral minoxidil at low dose has been proposed as a safe alternative. This study reviewed articles in which oral minoxidil was used to treat hair loss to determine its efficacy and safety as an alternative to topical minoxidil.
[METHODS] PubMed searches were performed to identify articles discussing oral minoxidil as the primary form of treatment for hair loss published up to April 2020.
[RESULTS] A total of 17 studies with 634 patients were found discussing the use of oral minoxidil as the primary treatment modality for hair loss. Androgenetic alopecia was the most studied condition, but other conditions included telogen effluvium, lichen planopilaris, loose anagen hair syndrome, monilethrix, alopecia areata, and permanent chemotherapy-induced alopecia.
[LIMITATIONS] Larger randomized studies comparing the efficacy/safety of different doses with standardized objective measurements will be needed to clarify the best treatment protocol.
[CONCLUSION] Oral minoxidil was found to be an effective and well-tolerated treatment alternative for healthy patients having difficulty with topical formulations.
[OBJECTIVE] In recent years, oral minoxidil at low dose has been proposed as a safe alternative. This study reviewed articles in which oral minoxidil was used to treat hair loss to determine its efficacy and safety as an alternative to topical minoxidil.
[METHODS] PubMed searches were performed to identify articles discussing oral minoxidil as the primary form of treatment for hair loss published up to April 2020.
[RESULTS] A total of 17 studies with 634 patients were found discussing the use of oral minoxidil as the primary treatment modality for hair loss. Androgenetic alopecia was the most studied condition, but other conditions included telogen effluvium, lichen planopilaris, loose anagen hair syndrome, monilethrix, alopecia areata, and permanent chemotherapy-induced alopecia.
[LIMITATIONS] Larger randomized studies comparing the efficacy/safety of different doses with standardized objective measurements will be needed to clarify the best treatment protocol.
[CONCLUSION] Oral minoxidil was found to be an effective and well-tolerated treatment alternative for healthy patients having difficulty with topical formulations.
【연구 목적】 국소 미녹시딜(topical minoxidil)은 효과적인 탈모 치료제이나 1일 2회 도포의 번거로움, 모발 결의 변화, 두피 자극 등으로 순응도가 낮은 한계가 있다.
APA 7
Randolph, M., & Tosti, A. (2021). Oral minoxidil treatment for hair loss: A review of efficacy and safety.. Journal of the American Academy of Dermatology, 84(3), 737-746. https://doi.org/10.1016/j.jaad.2020.06.1009
Vancouver
Randolph M, Tosti A. Oral minoxidil treatment for hair loss: A review of efficacy and safety. Jour. Amer. Acad. Derm.. 2021;84(3):737-746. doi:10.1016/j.jaad.2020.06.1009
AMA 11
Randolph M, Tosti A. Oral minoxidil treatment for hair loss: A review of efficacy and safety. Jour. Amer. Acad. Derm.. 2021;84(3):737-746. doi:10.1016/j.jaad.2020.06.1009
Chicago
Randolph, M., and Tosti, A.. 2021. "Oral minoxidil treatment for hair loss: A review of efficacy and safety." Journal of the American Academy of Dermatology 84 (3): 737-746. https://doi.org/10.1016/j.jaad.2020.06.1009
MLA 9
Randolph, M., and Tosti A. "Oral minoxidil treatment for hair loss: A review of efficacy and safety." Journal of the American Academy of Dermatology, vol. 84, no. 3, 2021, pp. 737-746. doi:10.1016/j.jaad.2020.06.1009.
PMID
32622136 ↗
추출된 의학 개체 (NER)
전체 NER 표 보기
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 약물 | minoxidil
|
미녹시딜 | dict | 8 | |
| 해부 | scalp
|
두피 | dict | 1 | |
| 질환 | androgenetic alopecia
|
안드로겐성 탈모 | dict | 1 | |
| 질환 | alopecia areata
|
원형 탈모증 | dict | 1 | |
| 질환 | telogen effluvium
|
휴지기 탈모 | dict | 1 |
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
인용 관계
그래프 OA 노드: 8/8 (100%)
· 참조 0편 · 후속 8편
이 논문을 인용한 후속 연구 20
- Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considera…
- Androgenetic Alopecia: Therapy Update.
- Integrative and Mechanistic Approach to the Hair Growth Cycle and Hair Loss.
- Regenerative medicine strategies for hair growth and regeneration: A narrative review of literature.
- Treatment of Androgenetic Alopecia: Current Guidance and Unmet Needs.
- Prevention and Treatment of Chemotherapy-Induced Alopecia: What Is Available and What Is Coming?
- Topical Treatment for Scarring and Non-Scarring Alopecia: An Overview of the Current Evidence.
- Alopecia Areata: Burden of Disease, Approach to Treatment, and Current Unmet Needs.
- Hair-Growth-Promoting Effects of the Fish Collagen Peptide in Human Dermal Papilla Cells and C57BL/6…
- Recent Advances in Understanding of the Etiopathogenesis, Diagnosis, and Management of Hair Loss Dis…
- Pericardial, pleural effusion and anasarca: A rare complication of low-dose oral minoxidil for hair …
- Status of research on the development and regeneration of hair follicles.
- Hair follicle-targeting drug delivery strategies for the management of hair follicle-associated diso…
- Management of hair loss after severe acute respiratory syndrome coronavirus 2 infection: Insight int…
- Exosomes derived from Umbilical cord mesenchymal stem cell promote hair regrowth in C57BL6 mice thro…
- Nitric oxide synergizes minoxidil delivered by transdermal hyaluronic acid liposomes for multimodal …
- Systemic Minoxidil Accidental Exposure in a Paediatric Population: A Case Series Study of Cutaneous …
- Oral minoxidil for late alopecia in cancer survivors.
- Chemotherapy-Induced Alopecia by Docetaxel: Prevalence, Treatment and Prevention.
- Hair Thickness Growth Effect of Adenosine Complex in Male-/Female-Patterned Hair Loss via Inhibition…
같은 제1저자의 인용 많은 논문 (1)
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
📖 비슷한 OA 논문 — 같은 카테고리, 무료 전문 가능
-
Alopecia areata.
TL;DRAlopecia areata is difficult to manage medically, but recent advances in understanding the molecular mechanisms have revealed new treatments and the possibility of remission in the…
-
Epidemiology and burden of alopecia areata: a systematic review.
TL;DRAA is the most prevalent autoimmune disorder and the second most prevalent hair loss disorder after androgenetic alopecia, and the lifetime risk in the global population is approxi…
-
Androgenetic alopecia: a review.
TL;DRA systematic review of the literature and candidate gene and genome-wide association studies have reported that single-nucleotide polymorphisms at different genomic loci are associ…
-
Two Phase 3 Trials of Baricitinib for Alopecia Areata.
TL;DRIn two phase 3 trials involving patients with severe alopecia areata, oral baricitinib was superior to placebo with respect to hair regrowth at 36 weeks.
-
Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics.
TL;DRAlthough a variety of medical, surgical, light‐based and nutraceutical treatment options are available to slow or reverse the progression of AGA, it can be challenging to select ap…